Transcatheter Closure of Atrial Septal Defect: One Center Experience and Mid-Term Follow-Up
Downloads
Objectives: The aim of this study is to present our center’s experience with device closure of atrial septal defects.
Introduction: Atrial septal defects (ASD) constitute the most frequent congenital heart disease in adults and ostium secundum (OS) is the most common type. Device closure of ASD is currently accepted as the treatment of choice.
Methods: Retrospective study, over a five-year period from 2016 to 2021. All patients who benefited from OS-ASD closure were included.
Results: Twenty-three patients were recruited. All patients had a significant shunt. The majority were female (69,9%) and the average age was 30,39 years; age range 6 – 70. The average hospital admission time was 3 ± 1 days. Dyspnea (≥ NYHA II) was noted in 62%. Closure success rate was 95,7%. During Follow up, an improvement in functional status was observed in all cases. A significant decrease in right cavities dilatation as well as pulmonary arterial pressure has been reported.
Conclusion: Device closure of secundum atrial septal defects demonstrates a high procedural success rate with a low incidence of complications in the follow up period.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the management of adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2008;118(23):2395–2345.
Cowley CG, Lloyd TR, Bove EL, et al. Comparison of results of closure of secundum atrial septal defect by surgery versus Amplatzer septal occluder. Am J Cardiol 2001;88:589-91. [Crossref] [PubMed]
Du ZD, Hijazi ZM, Kleinman CS, et al. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 2002;39:1836-44. [Crossref] [PubMed]
Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J 2006;151(1): 228–34.
Walters DL, Boga T, Burstow D, Scalia G, Hourigan LA, Aroney CN. Percutaneous ASD Closure in a Large Australian Series: Short- and Long-Term Outcomes. Heart, Lung and Circulation. 1 sept 2012;21(9):572‑5.
Atashband A, Lakkis N. First Comprehensive Analysis of Outcomes in Adult Patients after Percutaneous Closure of Isolated Secundum Atrial Septal Defects. Cardiovasc Hematol Agents Med Chem 2015;13:63–9.
Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J 2006;151(1): 228–34
Teo, K.S., Dundon, B.K., Molaee, P. et al. Percutaneous closure of atrial septal defects leads to normalisation of atrial and ventricular volumes. J Cardiovasc Magn Reson 10, 55 (2008). https://doi.org/10.1186/1532-429X-10-55
Brochu M-C, Baril J-F, Dore A, Juneau M, De Guise P, Mercier L-A. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation 2002;106:1821–6.
doi:10.1161/01.cir.0000029924.90823.e0.
Boudiche S, Chatti S, Amroussia R, Mghaieth F, Ziadi J, Farhati A, Ben Hammamia M, Tekaya MA, Ouali S, Guedira F, Denguir R, Mourali MS. Atrial septal defect closure in adults: A ten-year experience. Tunis Med. 2019 Dec;97(12):1362-1369. PMID: 32173806.
All Content should be original and unpublished.
